Stock ANRO ALTO NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Alto Neuroscience, Inc.

Equities

ANRO

US02157Q1094

Market Closed - Nyse
Other stock markets
 16:00:03 2024-06-21 EDT 		5-day change 1st Jan Change
11 USD -0.45% Intraday chart for Alto Neuroscience, Inc. -8.56% 0.00%
06-20 Alto Neuroscience, Inc. Initiates Phase 2 Study of ALTO-101, Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia CI
05-21 Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 12.44 16.10 12.96
Spread/Res.-11.58%-31.68%-15.12%
Spread/Supp.+12.02%+31.42%+5.06%
Support 9.820 8.370 10.47

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. ANRO Stock
  4. Charts Alto Neuroscience, Inc.